ASSAY and Drug Development Technologies This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Implementation of Quality by Design Approaches for Development and Validation of Reverse-Phase High-Performance Liquid Chromatography Assay Method for Determination of Glycyrrhizin in Nanoformulation
ASSAY and Drug Development Technologies, Ahead of Print. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - December 26, 2023 Category: Drugs & Pharmacology Authors: Jitu Halder Ivy Saha Tushar Kanti Rajwar Biswakanth Kar Goutam Ghosh Goutam Rath Source Type: research
Acknowledgment of Reviewers 2023
ASSAY and Drug Development Technologies, Ahead of Print. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - December 22, 2023 Category: Drugs & Pharmacology Source Type: research
Liver-Targeting Composite Nanocarrier Delivery System Based on Chitosan Nanoparticles and Phospholipid Complexes
ASSAY and Drug Development Technologies,Volume 21, Issue 8, Page 357-368, November/December 2023. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - December 12, 2023 Category: Drugs & Pharmacology Authors: Fanming Kong Jingmeng Sun Yue Hu Wenkai Huo Dongdong Li Weiyu Zhang Source Type: research
α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line
ASSAY and Drug Development Technologies, Ahead of Print. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - November 21, 2023 Category: Drugs & Pharmacology Authors: Pallavi Sandal Preeti Patel Dilpreet Singh Ghanshyam Das Gupta Balak Das Kurmi Source Type: research
A Short Appraisal of Biomimetic Hydrogels to Improve Penetration of Poorly Permeable Drugs
ASSAY and Drug Development Technologies, Ahead of Print. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - November 21, 2023 Category: Drugs & Pharmacology Authors: Dilpreet Singh Sahil Arora Vimal Arora Source Type: research
Letter to the Editor: Concerns Regarding Ethical Issues in Reviewer Recommendations for Citations
ASSAY and Drug Development Technologies, Ahead of Print. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - November 15, 2023 Category: Drugs & Pharmacology Authors: Rajendra Awasthi Source Type: research
Drug Repurposing Patent Applications July –September 2023
ASSAY and Drug Development Technologies, Ahead of Print. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - November 10, 2023 Category: Drugs & Pharmacology Authors: Hermann A.M. Mucke Source Type: research
Letter to the Editor: Repurposing Tafenoquine as a Potential Inhibitor Against Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease via a Fluorescence Polarization Assay
ASSAY and Drug Development Technologies, Ahead of Print. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - November 6, 2023 Category: Drugs & Pharmacology Authors: Rui Zhang Haohao Yan Gangan Yan Xiaoping Liu Yunyu Chen Source Type: research
Determination of the Toxicity Preferences of Ocular Drug Delivery System by Comparing Two Different Toxicity Bioassays
ASSAY and Drug Development Technologies,Volume 21, Issue 7, Page 337-343, October 2023. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - October 11, 2023 Category: Drugs & Pharmacology Authors: Burcu Uner Meltem Ezgi Durgun Samet Ozdemir Cetin Tas Melike Uner Yildiz Ozsoy Source Type: research
Adjusting the Fitting of Fluorescence-Based Dose –Response Kinase Inhibition Assay to Account for Fluorescent Inhibitors
ASSAY and Drug Development Technologies,Volume 21, Issue 7, Page 331-336, October 2023. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - October 11, 2023 Category: Drugs & Pharmacology Authors: Guillaume A. Petit Source Type: research
Illuminating Insights: Clinical Study Harnessing Pharmacoscintigraphy for Permeation Study of Radiolabeled Nimesulide Topical Formulation in Healthy Human Volunteers
ASSAY and Drug Development Technologies,Volume 21, Issue 7, Page 325-330, October 2023. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - October 11, 2023 Category: Drugs & Pharmacology Authors: Nitin Sharma Kushagra Khanna Neeraj Kumar Ritu Karwasra Ashok Kumar Janakiraman Mogana Sundari Rajagopal Source Type: research
Formulation and Characterization of Nanoparticulate Drug Carrier System for Lacidipine
ASSAY and Drug Development Technologies,Volume 21, Issue 7, Page 309-324, October 2023. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - October 11, 2023 Category: Drugs & Pharmacology Authors: Ashveta Anant Dessai Mrunali Navin Kantak Cleona Elizabeth Mary DCruz Lalit Kumar Prashant Jivaji Bhide Rupesh Kalidas Shirodkar Source Type: research
Quality by Design Approach for Optimization of Microbial and pH-Triggered Colon-Targeted Tablet Formulation Using Carboxymethyl Tamarind Gum
ASSAY and Drug Development Technologies,Volume 21, Issue 7, Page 297-308, October 2023. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - October 11, 2023 Category: Drugs & Pharmacology Authors: Jaymin Patel Kaushika Patel Shreeraj Shah Source Type: research
Rosalind Franklin Society Proudly Announces the 2022 Award Recipient ; for Assay and Drug Development Technologies
ASSAY and Drug Development Technologies,Volume 21, Issue 5, Page 189-189, July 2023. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - July 14, 2023 Category: Drugs & Pharmacology Authors: Anaelle da Costa Source Type: research
Design, Synthesis, Molecular Docking, and Biological Evaluation of Isatin-Based Fused Heterocycles As Epidermal Growth Factor Receptor Inhibitors
ASSAY and Drug Development Technologies, Ahead of Print. (Source: ASSAY and Drug Development Technologies)
Source: ASSAY and Drug Development Technologies - July 12, 2023 Category: Drugs & Pharmacology Authors: Ankush Kumar Bhupinder Kumar Rohit Bhatia Source Type: research